Blood transcriptional signature of recombinant human erythropoietin administration and implications for antidoping strategies.
Durussel J, Haile DW, Mooses K, Daskalaki E, Beattie W, Mooses M, Mekonen W, Ongaro N, Anjila E, Patel RK, Padmanabhan N, McBride MW, McClure JD, Pitsiladis YP.
Durussel J, et al. Among authors: mooses m, mooses k.
Physiol Genomics. 2016 Mar;48(3):202-9. doi: 10.1152/physiolgenomics.00108.2015. Epub 2016 Jan 12.
Physiol Genomics. 2016.
PMID: 26757800
Clinical Trial.